BioSpace News Archive

Rhythm Pharmaceuticals, Inc. today reported financial results and provided a business update for the first quarter ended March 31, 2022.

Stryker (NYSE: SYK) announced today the publication of results from a multicenter, single-blinded, randomized controlled trial comparing Stryker’s InSpace implant with partial repair for the treatment of full-thickness massive irreparable rotator cuff tears (MIRCTs) in the Journal of Bone and Joint Surgery (JBJS).

AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting.

ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022.

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services, today announced results for the first quarter ended March 31, 2022.

Xcell Biosciences Inc. today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.

Foldax® , Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic heart valve.

Baxter International Inc., a leading global medtech company, announced an increase in the company’s quarterly cash dividend to a rate of $0.29 per share of common stock.

Achilles Therapeutics plc today announced that the Company will be taking part in the following conferences in May.

The U.S. Food and Drug Administration (FDA) has cleared ZEUS Scientific’s dIFine® digital immunofluorescence system* for use with ZEUS’ ANA HEp-2 indirect fluorescent antibody (IFA) assay.